According to Intra-Cellular Therapies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:09 PM, company Chief Medical Officer, Durgam Suresh K. disclosed selling 2,734 shares at a cost of $39.25. At the time of this transaction (Feb 19), this trade was worth $107,310 in […]
According to Karyopharm Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:09 PM, company Chief Executive Officer, Kauffman Michael disclosed selling 9,495 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $140,822 in total. […]
According to Karyopharm Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:09 PM, company Chief Executive Officer, Kauffman Michael disclosed selling 9,495 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $140,822 in total. […]
According to Intra-Cellular Therapies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:07 PM, company EVP, Chief Commercial Officer, Neumann Mark disclosed selling 5,184 shares at a cost of $39.22. At the time of this transaction (Feb 19), this trade was worth $203,308 in […]
According to Intra-Cellular Therapies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:05 PM, company SVP of Finance CFO, Hineline Lawrence J. disclosed selling 10,442 shares at a cost of $39.23. At the time of this transaction (Feb 19), this trade was worth $409,625 […]
According to Intra-Cellular Therapies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:03 PM, company EVP and General Counsel, Halstead Michael disclosed selling 11,139 shares at a cost of $39.24. At the time of this transaction (Feb 19), this trade was worth $437,133 in […]
According to Intra-Cellular Therapies, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:01 PM, company Chairman, President & CEO, Mates Sharon disclosed selling 27,847 shares at a cost of $39.23. At the time of this transaction (Feb 19), this trade was worth $1,092,436 in […]
According to Smartsheet Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 07:56 PM, company Chief People & Culture Officer, Hamilton Kara disclosed selling 4,201 shares at a cost of $79.43. At the time of this transaction (Feb 18), this trade was worth $333,685 in […]
According to Carvana Co.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 07:52 PM, company 10% Owner, Garcia Ernest C. Ii disclosed selling 20,207 shares at a cost of $309.03. At the time of this transaction (Feb 19), this trade was worth $6,244,631 in total. […]
According to Carvana Co.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 07:51 PM, company 10% Owner, Garcia Ernest C. Ii disclosed selling 39,793 shares at a cost of $301.47. At the time of this transaction (Feb 19), this trade was worth $11,996,574 in total. […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
